Author | Fonseca, Érica L. | |
Author | Morgado, Sérgio M. | |
Author | Freitas, Fernanda S. | |
Author | Bighi, Nathalia S. | |
Author | Cipriano, Rosângela | |
Author | Vicente, Ana Carolina P. | |
Access date | 2023-05-25T21:40:18Z | |
Available date | 2023-05-25T21:40:18Z | |
Document date | 2023 | |
Citation | FONSECA, Érica L. et al. Genomic characterization of a pandrug-resistant Klebsiella pneumoniae belonging to the high-risk ST11 in the Brazilian Amazon region. bioRxiv preprint, p. 1- 15, Apr. 2023. | en_US |
URI | https://www.arca.fiocruz.br/handle/icict/58733 | |
Language | eng | en_US |
Publisher | bioRxiv preprint | en_US |
Rights | open access | en_US |
Subject in Portuguese | Klebsiella pneumoniae | en_US |
Subject in Portuguese | PDR | en_US |
Subject in Portuguese | Resistência à colistina | en_US |
Subject in Portuguese | Resistência à Tigeciclina | en_US |
Subject in Portuguese | acrAB | en_US |
Subject in Portuguese | ompK | en_US |
Title | Genomic characterization of a pandrug-resistant Klebsiella pneumoniae belonging to the high-risk ST11 in the Brazilian Amazon region | en_US |
Type | Preprint | en_US |
Abstract | Pandrug-resistant (PDR) K. pneumoniae has been reported sporadically in many countries and remains rare in Brazil. The lack of genomic studies limits the comprehension of the determinants mostly involved with the PDR emergence in K. pneumoniae. This study aimed to unravel the main genetic determinants involved with the PDR background of a clinical ST11 K. pneumoniae recovered in the Brazilian Amazon region. The carbapenem-resistant Kp196 was submitted to WGS and its intrinsic and acquired resistome was assessed by CARD and comparison with wild-type genes. Kp196 resistome was composed of acquired resistance determinants and mutations in chromosomal genes. Among the formers, blaCTX-M-15 and blaNDM-1, blaOXA 9, blaOXA-1, aadA1, aacA4, strAB, aph(3’)-VI, aac(3)-IId, qnrS1, qnrB1, oqxAB, dfrA14, 31 sul2, catB3 were found in the vicinity of mobile genetic elements, which could 32 contribute to their spread. Kp196 colistin resistance was multifactorial and attributed to 33 modifications in ArnT (M114L/V117I/R372K), PhoQ (D150G), and the mgrB 34 disruption by ISKpn25. Besides the presence of qnr and oqxAB genes, Kp196 also 35 presented altered GyrA (S83I) and ParC (S80I). An in-block deletion in the repressor 36 RamR, contributing to acrAB overexpression, and the presence of an enhanced-function 37 AcrB variant (S966A), probably led to the Kp196 multidrug and tigecycline resistance. 38 Insertions, in-block deletion, and missense mutations were involved with ompK35-36-39 37 inactivation, also accounting for the Kp196 multidrug resistance, including 40 carbapenems. The Kp196 PDR profile, especially the carbapenem resistance, was due to the accumulation of different mechanisms, in which modifications in housekeeping genes accounted for a more stable resistome. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Molecular de Microrganismos. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Molecular de Microrganismos. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Molecular de Microrganismos. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Molecular de Microrganismos. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | São Domingos Hospital, São Luís do Maranhão, Brasil. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Molecular de Microrganismos. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Molecular de Microrganismos. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | São Domingos Hospital, São Luís do Maranhão, Brasil. | en_US |
Subject | Klebsiella pneumoniae | en_US |
Subject | ompK | en_US |
Subject | acrAB | en_US |
Subject | Untreatable bacteria | en_US |
Subject | Tigecycline resistance | en_US |
Subject | PDR | en_US |
Embargo date | 2028 | |